Indeed, it has long been known that cytotoxic cells with this double T/NK phenotype are rare but present (from 1% to 5%) in circulating blood as originally described by Lanier [1], and are capable of lysing a broad array of tumor cell targets in a non-MHC-restricted manner. The gene discussed is HLA-C; the disease is neoplasm.